StockWatch
·
Healthcare Research- Analytics & Technology
Board Meeting10 Jul 2026, 02:50 pm

Indegene Ltd Board Meeting on July 30, 2026 for Q1 FY27 Results

AI Summary

Indegene Ltd has announced that its Board of Directors will convene on July 30, 2026. The primary agenda items include the consideration and approval of the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The meeting will also address the allotment of shares under the RSU Scheme 2020 and ESOP Scheme 2020. The trading window for securities will remain closed from July 1, 2026, until 48 hours after the declaration of the financial results.

Key Highlights

  • Board meeting scheduled for July 30, 2026.
  • To consider unaudited standalone and consolidated financial results for Q1 FY27.
  • Approval for share allotment under RSU and ESOP schemes.
  • Trading window closure in effect until results declaration.